Analystreport

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at SVB Leerink LLC from $42.00 to $46.00. They now have an "outperform" rating on

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report